menu
    • menu

    Company profile for Dermaliq Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dermaliq Therapeutics, Inc., is a private pharmaceutical company with a therapeutic focus on dermatology, founded in 2021 through a spin-off from Novaliq GmbH. Our mission is to develop a new generation of premium topical therapies and medical skin care products with greater efficacy and fewer unwanted side effects for millions of patients. The technology offers superior bioavailability and stability for many active ingredien...
    Dermaliq Therapeutics, Inc., is a private pharmaceutical company with a therapeutic focus on dermatology, founded in 2021 through a spin-off from Novaliq GmbH. Our mission is to develop a new generation of premium topical therapies and medical skin care products with greater efficacy and fewer unwanted side effects for millions of patients. The technology offers superior bioavailability and stability for many active ingredients combined with a cosmetic acceptability that was previously hard to achieve for topically applied drugs..

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Dermaliq TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Wilmington, Delaware
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://dermaliq.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    DEBRA, Dermaliq Partner On Epidermolysis Bullosa Drug Delivery
    DEBRA, Dermaliq Partner On Epidermolysis Bullosa Drug Delivery

    28 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/28/3089172/0/en/DEBRA-Research-and-Dermaliq-Enter-into-a-Strategic-Collaboration-to-Advance-Cutaneous-Drug-Delivery-for-Epidermolysis-Bullosa.html

    GLOBENEWSWIRE
    28 May 2025
    Share Share
    Dermaliq Strengthens Board To Advance Alopecia Drug
    Dermaliq Strengthens Board To Advance Alopecia Drug

    05 Feb 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-02-07/dermaliq-strengthens-scientific-medical-advisory-board-with-renowned-hair-research-expert-ralf-paus-md-dsc-frsb-to-advance-alopecia-drug-development

    PHARMAWEB
    05 Feb 2025
    Share Share
    Dermaliq Announces First Participant Randomized in Phase 1b/2 Trial of DLQ01
    Dermaliq Announces First Participant Randomized in Phase 1b/2 Trial of DLQ01

    14 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221214005635/en

    BUSINESSWIRE
    14 Dec 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search